Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Physical activity, height, and smoking affect prostate cancer risk.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Finasteride may cause kidney damage.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Voriconazole can cause serious side effects, especially in long-term use.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

The young woman has a benign, hereditary skin condition with no signs of a more serious syndrome.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.